Malignant Neoplasm of Stomach Active Not Recruiting Phase 2 Trials for Leucovorin (DB00650)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01443065MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal AdenocarcinomaTreatment
NCT01896531A Study of GDC-0068 in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction CancerTreatment
NCT01498289S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction CancerTreatment
NCT01913639FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric CancerTreatment